Another PCSK9 Drug Proves Its Mettle for Kids With Inherited High Cholesterol

(MedPage Today) -- For kids with heterozygous familial hypercholesterolemia (HeFH) uncontrolled by statins, adding alirocumab (Praluent) reduced low-density lipoprotein cholesterol (LDL-C), a randomized clinical trial showed. The PCSK9 inhibitor...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news